NCT02268929 - A German Study Evaluating the Efficacy and the Benefit of Integrated Personalized Diabetes Management (PDM) for Type 2 Diabetes Patients. | Biotech Hunter

Enrollment

414

Participants

Timeline

Start Date

October 14, 2014

Primary Completion Date

January 11, 2017

Study Completion Date

February 9, 2017

Conditions

Diabetes Mellitus, Type 2

Interventions

DEVICE

Accu-Chek Smart Pix Software

Software with adherence evaluation software used according to Integrated Personalized Diabetes Management (PDM)

DEVICE

Accu-Chek Smart Pix readout Device

Smartpix device for data upload out from blood glucose meter devices

Trial Locations (50)

16303

Schwedt

17268

Beutel/Templin

23562

Lübeck

23858

Reinfeld

26871

Papenburg

27572

Bremerhaven

30163

Hanover

31167

Bockenem

32584

Löhne

35390

Giessen

35460

Staufenberg

35584

Wetzlar

35745

Herborn

37127

Dransfeld

44805

Bochum

45329

Essen

45355

Essen

45359

Essen

47803

Krefeld

49661

Cloppenburg

50169

Kerpen

52349

Düren

52372

Kreuzau

53937

Schleiden

54290

Trier

54338

Schweich

54343

Föhren

Schweich

55116

Mainz

55130

Mainz

55545

Bad Kreuznach

56414

Meudt

57072

Siegen

63110

Rodgau

69502

Hemsbach

72461

Albstadt

72488

Sigmaringen

99444

Blankenhain

08209

Auerbach/Vogtland

04824

Beucha

04552

Borna

01309

Dresden

04910

Elsterwerda

09326

Geringswalde

06366

Köthen

04315

Leipzig

01662

Meissen

01589

Riesa

09328

Rochlitz

07570

Weida

All Listed Sponsors

collaborator

Roche Diabetes Care

INDUSTRY

lead

Hoffmann-La Roche

INDUSTRY